recombinant opticin (Opticin Therapeutics)

N/A

Report date: 2025/01/26 17:44:08

Base Information

Drug Namerecombinant opticin (Opticin Therapeutics)
Drug Alias Nameangiogenesis inhibitor (University of Manchester)recombinant opticin (University of Manchester)recombinant opticin
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsRetinopathy of PrematurityDiabetic RetinopathyEye Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Manchester
China Registration ClassN/A

Develop Information

Active CompaniesOpticin Therapeutics
Inactive CompaniesThe University of Manchester I3 LtdThe University Of Manchester
Active IndicationsRetinopathy of PrematurityDiabetic Retinopathy
Inactive IndicationsEye DiseasesArthritisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A